Thermo Fisher Scientific (TMO) PT Raised to $580 at RBC Capital
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $605.00 +0.89%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
RBC Capital analyst Dan Leonard raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $580.00 (from $490.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at Morgan Stanley
- Rapid7 (RPD) PT Raised to $13 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
